Authors: Blum VF, Cimerman S, Huneter JR, Tierno P, Lacerda A, Soeiro A PMID: 34222847 PMCID: PMC8235996 DOI: 10.1016/j.eclinm.2021.100981 Abstract Background: The absence of specific antivirals to treat COVID-19 leads to the repositioning of candidates' drugs. Nitazoxanide (NTZ) has a broad antiviral effect. Methods: This was a randomized, double-blind pilot clinical trial comparing NTZ 600 [...]